The knockdown of REG4 or an anti-REG4 antibody both attenuated the cell viability of pancreatic cancer cells, while rhREG4 exposure showed the opposite effect in a dose-dependent manner (Eguchi et al., 2009). The gene discussed is REG4; the disease is pancreatic neoplasm.